Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Invasive Species

Invasive species: Any kind of living organism—an amphibian (like the cane toad), plant, insect, fish, fungus, bacteria, or even an organism's seeds or eggs—that is not native to an ecosystem and causes harm. They can harm the environment, the economy, or even human he...

Buzz on the Bullboards: Top Talked About Stocks During Volatile Times

(Image via Tilray Inc.) A leading global cannabis-lifestyle and consumer packaged goods company, Tilray Inc. ( NASDAQ: TLRY , Forum ) has operations in Canada, the United States, Europe, Australia, and Latin America. SweetWater Brewing Company , a subsidiary o...

Proteostasis Therapeutics Reports Positive Results from European Cystic Fibrosis Research

Proteostasis Therapeutics' shares traded higher today after the company reported positive results in its European Cystic Fibrosis study of organoids grown from human stem cells. The firm believes the ongoing ex-vivo study supports initiation of a human clinical trial in mid-20...

Pope Resources Shares Rise 35% on Rayonier $554 Million Takeover Bid

Pope Resources LP shares set a new 52-week intraday high price today after the timber resources firm announced that it agreed to be acquired by Rayonier for $554 million, or $126.91 per unit. The transaction is expected to close in mid-year 2020 subject to approval of Pope's u...

FDA Grants Ampio Pharma Approval to Begin Phase 1 Trial in COVID-19 Patients

Ampio Pharmaceuticals' shares traded higher after the company reported that the FDA cleared the firm to proceed with human trials of its Investigative New Drug application for intravenous AmpionTM for treatment in COVID-19 affected patients on supplemental oxygen. ...

Titans in Mining: An Interview with Rick Rule, Part 2

After the first part of my interview with Rick Rule generated quite a bit of attention, I'm pleased to continue with the interview in this second, and equally extensive, part, in a series of no less than four parts. As Rick is one of the best speakers in the mining sect...

Is a Local Top in Gold At Hand?

In yesterday’s analysis on gold price in December 2019 , we wrote that while the outlook for the yellow metal for the following months was bearish, it was bullish for the short term. And indeed – gold, silver, and mining stocks rallied. In fact, the rally cont...

A psychedelic renaissance

Fifty-three years after LSD was banned by the FDA, psychedelic drugs are making a comeback. Only instead of being the pills, mushrooms and acid tabs that helped college students to “turn on, tune in, drop out” Timothy Leary-style, today’...

S&P 500 Nearing Previous Highs, What’s Next?

Wednesday’s trading session didn’t change much. Stocks extended their short-term consolidation following Monday’s rebound off a support level. The S&P 500 index continues to trade within a four-week-long consolidation after the e...

S&P 500’s Breakout? Not Out of Woods Yet

Wednesday’s trading session was bullish, as stocks retraced their Tuesday’s decline and got close to the recent local highs again. Will the S&P 500 index break higher today? The U.S. stock market indexes gained 0.9-1.3% on Wednesday, as they...
1 2 3 4 5 6 7 8 9 10 ...